Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Audio By Carbonatix

CHICAGO--(BUSINESS WIRE)--Feb 26, 2026--

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that it will participate in the Morgan Stanley Technology, Media, and Telecom Conference on Tuesday, March 3 in San Francisco. Eric Lefkofsky, Tempus Founder and CEO, will participate in a fireside chat at 9:15 AM PST.

The live webcast may be accessed directly using the following link: https://event.webcasts.com/starthere.jsp?ei=1753938&tp_key=e25fc24c17&tp_special=8. A recording will be made available on the Events page of Tempus’ Investor Relations website.

About Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260226785621/en/

CONTACT: Tempus Communications

Hanah Heintzelman

[email protected]

Tempus Investor Relations

Elizabeth Krutoholow

[email protected]

KEYWORD: ILLINOIS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SOFTWARE PHARMACEUTICAL GENERAL HEALTH HEALTH ARTIFICIAL INTELLIGENCE DATA MANAGEMENT HEALTH TECHNOLOGY TECHNOLOGY

SOURCE: Tempus AI, Inc.

Copyright Business Wire 2026.

PUB: 02/26/2026 08:30 AM/DISC: 02/26/2026 08:30 AM

http://www.businesswire.com/news/home/20260226785621/en